ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: SA-PO157

OTUD5 Mediates GPX4 Stability and Ferroptosis in Renal Tubular Cells During Ischemia-Reperfusion Injury

Session Information

  • AKI: Mechanisms - III
    November 04, 2023 | Location: Exhibit Hall, Pennsylvania Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Liu, Jun, University of California Davis, Davis, California, United States
  • Hsu, Ssu-Wei, University of California Davis, Davis, California, United States
  • Guo, Fujia, University of California Los Angeles, Los Angeles, California, United States
  • Oshiro, Lindsay, University of California Davis, Davis, California, United States
  • Yan, Xiang-Ming, Children's Hospital of Soochow University, Suzhou, Jiangsu, China
  • Chen, Ching-Hsien, University of California Davis, Davis, California, United States
Background

Acute kidney injury (AKI) is a severe kidney disease often linked with renal tubular cell ferroptosis, an iron-dependent, non-apoptotic cell death characterized by lipid peroxide accumulation. This can be triggered by ischemia-reperfusion (I/R) and typically results from decreased glutathione peroxidase 4 (GPX4) expression. However, the specific molecular events underlying GPX4 reduction following I/R remain poorly understood.

Methods

Our research involved identifying and characterizing the role of GPX4-interacting proteins in renal tubular cells. We also studied the susceptibility of renal regions to I/R injury using spatial transcriptomics. Both in vitro assays and in vivo experiments using mice with conditionally deleted Otud5 were employed to evaluate the function of OTU deubiquitinase 5 (OTUD5) in ferroptosis and AKI.

Results

OTUD5 was found to interact with and stabilize GPX4, conferring resistance to ferroptosis in renal tubular cells. During I/R, the inability of OTUD5 to deubiquitinate, triggered by mTORC1-mediated macroautophagy, led to GPX4 degradation and ferroptosis. Spatial transcriptomics revealed hyperactivity of cell ferroptosis and autophagy in the region between the kidney's inner cortex and medulla outstrip, susceptible to I/R injury. Functionally, OTUD5 deletion resulted in heightened renal tubular cell ferroptosis in vitro, and mice with tubular epithelial cell-specific Otud5 deletion demonstrated exacerbated AKI in response to I/R. Conversely, adeno-associated virus-mediated Otud5 delivery reduced ferroptosis and promoted renal function recovery.

Conclusion

Our findings unveil a novel autophagy-dependent ferroptosis module: I/R-induced OTUD5 macroautophagy leads to GPX4 degradation and tubular cell ferroptosis. Targeting this pathway may offer a potential therapeutic strategy for I/R-related kidney diseases.

Funding

  • Other U.S. Government Support